Live Breaking News & Updates on Nagoya University In Aichi
Stay updated with breaking news from Nagoya university in aichi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Having a good laugh can help cheer you up when you've had a very stressful day. According to research published in the journal Preventive Medicine, laughing with your friends may also help [.] ....
Credit Justin Hicks / IPB News Clinical trials for antiviral drugs to treat COVID-19 have produced inconsistent results. New research led by Indiana University says the problem may come down to how these trials are designed. Indiana University assistant research scientist Keisuke Ejima and researchers at Nagoya University in Aichi, Japan, created simulations based on clinical data to analyze how COVID-19 drug trials are designed. To best decrease the viral load, or the amount of virus in a person, the study found participants needed antiviral medication within two days of developing symptoms. But clinical trials on average get participants around five days after symptoms. ....
New Study Highlights Underlying Flaws In COVID-19 Antiviral Drug Clinical Trials wbaa.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wbaa.org Daily Mail and Mail on Sunday newspapers.
New Study Highlights Underlying Flaws In COVID-19 Antiviral Drug Clinical Trials Unable to load the audio player. playpausemuteunmute Article origination IPBS-RJC To best decrease the viral load, or the amount of virus in a person, the study found participants needed antiviral medication within two days of developing symptoms. Justin Hicks/IPB News Clinical trials for antiviral drugs to treat COVID-19 have produced inconsistent results. New research led by Indiana University says the problem may come down to how these trials are designed. Indiana University assistant research scientist Keisuke Ejima and researchers at Nagoya University in Aichi, Japan, created simulations based on clinical data to analyze how COVID-19 drug trials are designed. ....
Study reveals contributing factor to inconsistent results in clinical trials for COVID-19 drugs Jul 8 2021 A new study suggests that significant variation in the amount of virus from person to person may be a contributing factor to inconsistent findings reported in clinical trials for antiviral COVID-19 drugs. The study is led by Keisuke Ejima, an assistant research scientist at the Indiana University School of Public Health-Bloomington. A new study suggests that significant variation in the amount of virus from person to person may be a contributing factor to inconsistent findings reported in clinical trials for antiviral COVID-19 drugs. Photo courtesy of Getty Images ....